Objective: This work proposes a review of the antibodies which have been associated with
variant RHD and RHCE alleles, except null alleles. Background: The data on this topic is …

Red blood cell (RBC) transfusion is a critical component of optimal management for a broad
range of conditions. Regardless of the indication, pretransfusion testing is required to …

Objective To use a systematic, evidence‐based consensus process to develop definitions
for transfusion reactions in dogs and cats. Design Evidence evaluation of the literature was …

Patients with sickle cell disease (SCD) often receive red blood cell (RBC) transfusion
support for the prevention and management of many acute and chronic disease …

Red blood cell (RBC) transfusion is a major therapy for sickle cell disease (SCD). Patients
are at risk of forming antibodies to RBC antigens, which can result in the impossibility to find …

Red blood cell (RBC) transfusion support represents a critical component of sickle cell
disease (SCD) management. However, as with any therapeutic intervention, RBC …

Background Hyperhaemolysis is a rare and life‐threatening delayed haemolytic transfusion
reaction characterised by complement‐mediated destruction of both host and transfused red …

BACKGROUND Hemolytic transfusion reactions are a rare, yet serious complication of red
blood cell (RBC) transfusion. Patients with sickle cell disease (SCD) are at an increased risk …

Daratumumab, an anti-CD38 monoclonal antibody, is a new treatment for multiple myeloma
(MM)[1]. However, it would bind to the CD38 molecule on red blood cells (RBCs), causing …

Sickle cell disease (SCD) is the most prevalent genetic disorder in France. Many other
countries are also affected. Transfusion is still a key treatment for patients suffering from this …